231 related articles for article (PubMed ID: 18785317)
1. Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database.
Ranganath VK; Paulus HE; Onofrei A; Khanna D; Reed G; Elashoff DA; Kremer JM; Furst DE
J Rheumatol; 2008 Oct; 35(10):1966-71. PubMed ID: 18785317
[TBL] [Abstract][Full Text] [Related]
2. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
[TBL] [Abstract][Full Text] [Related]
4. Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up.
Graell E; Vazquez I; Larrosa M; Rodríguez-Cros JR; Hernández MV; Gratacós J; Gómez A; Cañete JD; Gómez-Puerta JA; Sanmartí R
Clin Exp Rheumatol; 2009; 27(2):284-91. PubMed ID: 19473570
[TBL] [Abstract][Full Text] [Related]
5. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
6. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs.
Radner H; Yoshida K; Frits M; Iannaccone C; Shadick NA; Weinblatt M; Smolen JS; Solomon DH
Rheumatology (Oxford); 2015 Nov; 54(11):2076-84. PubMed ID: 26163688
[TBL] [Abstract][Full Text] [Related]
7. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
Kavanaugh A; Keystone E; Greenberg JD; Reed GW; Griffith JM; Friedman AW; Saunders KC; Ganguli A
Rheumatology (Oxford); 2017 Jul; 56(7):1095-1101. PubMed ID: 28340006
[TBL] [Abstract][Full Text] [Related]
8. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
Ruban TN; Jacob B; Pope JE; Keystone EC; Bombardier C; Kuriya B
Clin Rheumatol; 2016 Mar; 35(3):759-63. PubMed ID: 26245721
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
Ranganath VK; Maranian P; Elashoff DA; Woodworth T; Khanna D; Hahn T; Sarkisian C; Kremer JM; Furst DE; Paulus HE
Rheumatology (Oxford); 2013 Oct; 52(10):1809-17. PubMed ID: 23813577
[TBL] [Abstract][Full Text] [Related]
10. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
[TBL] [Abstract][Full Text] [Related]
12. Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.
Mjaavatten MD; Radner H; Yoshida K; Shadick NA; Frits ML; Iannaccone CK; Kvien TK; Weinblatt ME; Solomon DH
Semin Arthritis Rheum; 2015 Feb; 44(4):399-404. PubMed ID: 25257807
[TBL] [Abstract][Full Text] [Related]
13. Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
Bird A; Oakden-Rayner L; Smith LA; Zeng M; Ray S; Proudman S; Palmer LJ
Clin Rheumatol; 2024 May; 43(5):1503-1512. PubMed ID: 38536518
[TBL] [Abstract][Full Text] [Related]
14. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
15. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.
Uhlig T; Lie E; Norvang V; Lexberg ÅS; Rødevand E; Krøll F; Kalstad S; Olsen IC; Kvien TK
J Rheumatol; 2016 Apr; 43(4):716-23. PubMed ID: 26879358
[TBL] [Abstract][Full Text] [Related]
16. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
17. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
18. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TW; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
Arthritis Res Ther; 2015 Nov; 17():325. PubMed ID: 26568428
[TBL] [Abstract][Full Text] [Related]
19. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
20. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
